Immucell (ICCC) Stock: Buy, Sell, or Hold?
$10.26
+0.04 (+0.39%)
▲
5d:
+0.1%
30d:
+6.88%
90d:
-6.56%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
BUY
HIGH Confidence (87%)
Quality Score
59/100
Position
FAIR
30-Day Fair Range
$9.91 – $10.59
Position: FAIR
Wall Street Target
$14.00
+36.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.60 / $10.65
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: ICCC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $10.26, which is considered fair relative to its 30-day fair value range of $9.91 to $10.59.
Technical Outlook: Technically, ICCC is in a downtrend. Immediate support is located at $9.60, while resistance sits at $10.64.
Market Sentiment: ICCC scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+36.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICCC is in a downtrend. Immediate support is located at $9.60, while resistance sits at $10.64.
Market Sentiment: ICCC scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+36.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$9.91 -
$10.59
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
Trading Range & Key Levels
30-Day Trading Range
$9.91 -
$10.59
Current vs Trading Range
FAIR
Support Level
$9.60
Resistance Level
$10.65
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.5% below Wall St target ($14.00)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Fundamental Context
Wall Street Target
$14.00
(+36.5%)
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
259.9%
Profit Margin
2.6%
Share ICCC Analysis
Share this live ICCC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ICCC)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment about an upcoming data release for $ICCC
Key Retail Themes:
upcoming data release
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:04 AM ET
Data refreshes hourly during market hours. Next update: 9:04 AM
Data refreshes hourly during market hours. Next update: 9:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 49 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 62 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ICCC Research Pages
